The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors

被引:45
作者
Hsieh, Jung-Feng
Wu, Shih Hsiung
Yang, Yu-Liang
Choong, Kee-Fong
Chen, Shui-Tein [1 ]
机构
[1] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
[2] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan
[3] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan
关键词
allopurinol; 6-aminopurine; 2-chloro-6(methylamino)purine; inhibitor;
D O I
10.1016/j.bmc.2007.03.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Xanthine oxidase (XO) is a key enzyme which can catalyze xanthine to uric acid causing hyperuricemia in humans. By using the fractionation technique and inhibitory activity assay, an active compound that prevents XO from reacting with xanthine was isolated from wheat leaf. It was identified by the Mass and NMR as 6-aminopurine (adenine). A structure-activity study based on 6-aminopurine was conducted. The inhibition of XO activity by 6-aminopurine (IC50 = 10.89 +/- 0.13 mu M) and its analogues was compared with that by allopurinol (IC50 = 7.82 +/- 0.12 mu M). Among these analogues, 2-chloro-6(methylamino)purine (IC50 = 10.19 +/- 0.10 mu M) and 4-aminopyrazolo[3,4-d]pyrimidine (IC50 = 30.26 +/- 0.23 mu M) were found to be potent inhibitors of XO. Kinetics study showed that 2-chloro-6(methylamino)purine is non-competitive, while 4-aminopyrazolo[3,4-d]pyrimidine is competitive against XO. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3450 / 3456
页数:7
相关论文
共 28 条
[1]
CHOLESTEROGENESIS - DEREPRESSION IN EXTRAHEPATIC TISSUES WITH 4-AMINOPYRAZOLO[3,4-D]PYRIMIDINE [J].
ANDERSEN, JM ;
DIETSCHY, JM .
SCIENCE, 1976, 193 (4256) :903-905
[2]
Bashir S, 2000, J Pak Med Assoc, V50, P207
[3]
METABOLIC STUDIES OF ALLOPURINOL AN INHIBITOR OF XANTHINE OXIDASE [J].
ELION, GB ;
KOVENSKY, A ;
HITCHING.GH ;
METZ, E ;
RUNDLES, RW .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (07) :863-&
[4]
Drug therapy - The management of gout [J].
Emmerson, BT .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) :445-451
[5]
2-styrylchromones as novel inhibitors of xanthine oxidase. A structure-activity study [J].
Fernandes, E ;
Carvalho, F ;
Silva, AMS ;
Santos, CMM ;
Pinto, DCGA ;
Cavaleiro, JAS ;
Bastos, MD .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2002, 17 (01) :45-48
[6]
Allopurinol, an inhibitor of xanthine oxidase, reduces uric acid levels and modifies the signs associated with copper deficiency in rats fed fructose [J].
Fields, M ;
Lewis, CG ;
Lure, MD .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (04) :595-600
[7]
Xanthine oxidase inhibitory activity of Lychnophora species from Brazil ("Arnica") [J].
Filha, Z. S. Ferraz ;
Vitolo, I. F. ;
Fietto, L. G. ;
Lombardi, J. A. ;
Saude-Guimaraes, D. A. .
JOURNAL OF ETHNOPHARMACOLOGY, 2006, 107 (01) :79-82
[8]
Góngora L, 2003, PLANTA MED, V69, P396, DOI 10.1055/s-2003-39715
[9]
Fatal allopurinol-induced hypersensitivity syndrome in asymptomatic hyperuricaemia [J].
Hammer, B ;
Link, A ;
Wagner, A ;
Böhm, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (47) :1331-1334
[10]
Harris MD, 1999, AM FAM PHYSICIAN, V59, P925